ClassID:

94478 āŽ˜

C07D239/04 - CPC Classification

Classification description:

Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members

Recent Application in this class:
#1
20250268854
2025-08-28

2-AMINO-5,5-DIMETHYLHEXANOIC ACID DERIVATIVES AS SORTILIN MODULATORS FOR USE IN THE TREATMENT OF DISEASE OF THE CENTRAL NERVOUS SYSTEM

#2
20250055035
2025-02-13

LITHIUM-ION BATTERY AND APPARATUS

#3
20250038266
2025-01-30

LITHIUM-ION BATTERY AND APPARATUS

#4
20240376328
2024-11-14

PHOTOCURABLE COMPOSITION

#5
20240174623
2024-05-30

Build UP Film Curable Compositions

#6
20240009153
2024-01-11

BUMETANIDE ANALOGS, COMPOSITIONS AND METHODS OF USE

#7
20230374370
2023-11-23

Corrosion inhibitor with improved performance at high temperatures

#8
20230373900
2023-11-23

CYCLOPROPENIUM COMPOUNDS, PROCESS FOR THEIR PREPARATION AND USE

#9
20220393236
2022-12-08

Lithium-ion battery and apparatus

#10
20220209296
2022-06-30

Lithium-ion battery and apparatus

#11
20220149434
2022-05-12

Lithium-ion battery and apparatus

#12
20220071935
2022-03-10

BUMETANIDE ANALOGS, COMPOSITIONS AND METHODS OF USE

#13
20210238469
2021-08-05

Corrosion inhibitor with improved performance at high temperatures

#14
20210143477
2021-05-13

Lithium-ion battery and apparatus

#15
20210143476
2021-05-13

Lithium-ion battery and apparatus

#16
20210139853
2021-05-13

Production of brown adipocytes

#17
20210135289
2021-05-06

Lithium-ion battery and apparatus

#18
20210135286
2021-05-06

Lithium-ion battery and apparatus

#19
20210075063
2021-03-11

Lithium-ion battery and apparatus

#20
20210036368
2021-02-04

Lithium-ion battery and apparatus

#21
20200127330
2020-04-23

Electrolyte and electrochemical device

#22
20190326634
2019-10-24

Electrolyte and electrochemical device

#23
20190185457
2019-06-20

HETEROCYCLIC COMPOUND, COMPOSITION INCLUDING THE SAME, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND

#24
20190151263
2019-05-23

BUMETANIDE ANALGOS, COMPOSITIONS, AND METHODS OF USE

#25
20170313683
2017-11-02

BTK inhibitor

#26
20150361054
2015-12-17

Phosphatidylinositol 3-kinase inhibitors

#27
20150104349
2015-04-16

N-alkyl-N′-poly(oxyalkyl)hexahydropyrimidine-quaternary ammonium salts and the use thereof as corrosion inhibitors

#28
20150080386
2015-03-19

Compounds for the treatment of proliferative disorders

#29
20150080350
2015-03-19

Bumetanide analogs, compositions and methods of use

#30
20140374706
2014-12-25

Compound, organic optoelectric device including the same and display device including the optoelectric device

#31
20140357862
2014-12-04

Silyl-protected nitrogen-containing cyclic compounds and making method

#32
20140038873
2014-02-06

Equilibrated dynamic mixtures to control the release of perfuming aldehydes and ketones

#33
20120004225
2012-01-05

BUMETANIDE, FUROSEMIDE, PIRETANIDE, AZOSEMIDE, AND TORSEMIDE ANALOGS, COMPOSITIONS AND METHODS OF USE

#34
20110301355
2011-12-08

Amidine compounds and herbicides

#35
20110160454
2011-06-30

Saturated N-heterocyclic carbene-ligand metal complex derivatives, preparing method thereof, and preparing method of silane compound by hydrosilylation reaction using the same as catalyst

#36
20100324001
2010-12-23

Novel Methods for the Treatment of Inflammatory Diseases

#37
20100111875
2010-05-06

TRISUBSTITUTED TRIAZAMACROCYCLIC COMPOUNDS AND THEIR USE AS CONTRAST AGENTS

#38
20100098650
2010-04-22

CONTROLLED RELEASE OF ACTIVE ALDEHYDES AND KETONES FROM EQUILIBRATED DYNAMIC MIXTURES

#39
20100093828
2010-04-15

Compounds for the treatment of proliferative disorders

#40
20100075978
2010-03-25

SULFONAMIDE DERIVATIVES AS BRADYKININ ANTAGONISTS

#41
20080306098
2008-12-11

Pharmacokinetics of protease inhibitors and other drugs

#42
20080247991
2008-10-09

Solution Additives For the Attenuation of Protein Aggregation

#43
20080146594
2008-06-19

Thrombopoietin activity modulating compounds and methods

#44
20080103190
2008-05-01

THROMBOPOIETIN ACTIVITY MODULATING COMPOUNDS AND METHODS

#45
20070010563
2007-01-11

Methods for the treatment of inflammatory diseases

#46
20060116417
2006-06-01

Thrombopoietin activity modulating compounds and methods

#47
20060084688
2006-04-20

Aromatic sulfone hydroxamic acid metalloprotease inhibitor

#48
20050161637
2005-07-28

Perfluoroallyloxy compound and liquid crystal composition containing the same

#49
20050080088
2005-04-14

Sulfonyl group containing compounds and their use for the treatment of erectile dysfunction

#50
20050014916
2005-01-20

Ruthenium complexes, process for preparation thereof, and processes for producing open-ring polymer of cycloolefins and hydrogenation products thereof by using the complex as catalyst